Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 78 Triple Negative Breast Neoplasms 9 Prostatic Neoplasms 8 Colorectal Neoplasms 8 Anatomic Stage I Breast Cancer AJCC v8 8 Neoplasms 6 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Breast Carcinoma In Situ 4 Lymphedema 3 Colonic Neoplasms 3 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Medication Adherence 2 Fatigue 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms, Male 2 Anxiety Disorders 2 Vomiting 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Signs and Symptoms 1 Sarcoma 1 Recurrence 1 Radiodermatitis 1 Pathologic Complete Response 1

Interventions

Zoledronic Acid 8 Psychiatric Rehabilitation 6 Analgesia 5 Acupuncture Therapy 5 Therapeutics 4 Bupivacaine 4 Surveys and Questionnaires 3 Radiotherapy 3 Ketamine 3 Early Intervention, Educational 3 Control Groups 3 Calcium 3 Yoga 2 Pregabalin 2 Music Therapy 2 Melatonin 2 Letrozole 2 Interviews as Topic 2 Fentanyl 2 Fatty Acids, Omega-3 2 Duloxetine Hydrochloride 2 Calcium Gluconate 2 Art Therapy 2 strontium chloride 1 pegfilgrastim 1 ixabepilone 1 exemestane 1 esmolol 1 cyclobenzaprine 1 Vitamin D 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pain × Standard of Care × Breast × Clear all

NCT02867644 2022-12-20

HYCOREMA

Institut de Cancérologie de Lorraine

Phase NA Terminated

Anxiety Disorders, Breast Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡